Association between white matter hyperintensities and altered cerebral blood flow in maintenance hemodialysis patients: a longitudinal study
-
Published:2024-01-24
Issue:1
Volume:25
Page:
-
ISSN:1471-2369
-
Container-title:BMC Nephrology
-
language:en
-
Short-container-title:BMC Nephrol
Author:
Li Mingan,Yang Wenbo,Song Lijun,Yang Zhenghan,Wang Zhenchang,Xian Junfang,Wang Hao
Abstract
Abstract
Objectives
To explore changes in cerebral blood flow (CBF) and white matter in hemodialysis patients.
Methods
Thirty-three hemodialysis patients who underwent two brain MRI at an interval of three years and 33 age- and sex-matched healthy controls (HC) underwent structural and arterial spin-labeling MRI examinations. Intergroup differences in CBF in the gray matter, white matter, and whole matter, and regional white matter hyperintensities (WMH) were analyzed. Based on the changes in CBF between the baseline and follow-up groups, the hemodialysis patients were divided into two subgroups: an increased CBF group and a decreased CBF group. Differences in CBF and WMH between the subgroups and HC were analyzed.
Results
Patients undergoing hemodialysis exhibited increased cerebral watershed (CW) WMH, deep WMH, and periventricular WMH (P < 0.01). The CBF of patients with decreased CBF was higher than that of HC at baseline (,P < 0.01) and lower than that of HC at follow-up (P < 0.01). Compared with the increased CBF group, obvious development of deep WMH was found in the decreased CBF group for the gray matter, white matter, and whole matter (P < 0.01).
Conclusions
WMH in hemodialysis patients were distributed in the deep white matter, periventricular white matter and CW, and progressed with the extension of hemodialysis duration. CBF in hemodialysis patients could manifest as both increased and decreased, and WMH in patients with decreased CBF developed severely with prolongation of hemodialysis duration.
Advances in knowledge
These findings provide a basis for exploring neuropathological changes of hemodialysis patients.
Funder
Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Foley RN, Collins AJ. End-stage renal disease in the United States. J Am Soc Nephrol. 2007;18(10):2644–8. 2. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O’Hare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA. Shahinian V. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017;69(3 Suppl 1):A7–A8. 3. Wang H, Han X, Li M, Yang ZH, Liu WH, Wang ZC. Long-term hemodialysis may affect enlarged perivascular spaces in maintenance hemodialysis patients: evidence from a pilot MRI study. Quant Imaging Med Surg. 2022;12(1):341–53. 4. Yeh YC, Kuo YT, Huang MF, Hwang SJ, Tsai JC, Kuo MC, Chen CS. Association of brain white matter lesions and atrophy with cognitive function in chronic kidney disease. Int J Geriatr Psychiatry. 2019;34(12):1826–32. 5. Peng D, Geriatric Neurology Group CSoG, Clinical Practice Guideline for Cognitive Impairment of Cerebral Small Vessel Disease Writing G. Clinical practice guideline for cognitive impairment of cerebral small vessel disease. Aging Med (Milton). 2019;2(2):64–73.
|
|